Page 16 - Celularity Inc News Today

KUALA LUMPUR (May 11): Based on corporate announcements and news flow today, stocks in focus for tomorrow (May 12) may include the following: Malayan Banking Bhd, FGV Holdings Bhd, Pos Malaysia Bhd, WTK Holdings Bhd, Public Bank Bhd, Bina Darulaman Bhd, Careplus Group Bhd, JF Technology Bhd, Media Chinese International Ltd, and Genting Bhd. Malayan Banking Bhds (Maybank) 100%-owned subsidiary Maybank Islamic Bhd today announced the buy-back of RM1.5 billion worth of Islamic bonds via private tr...

Share this article Share this article NEW YORK, May 10, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ: GXGX), a publicly-traded special purpose acquisition company, today reaffirmed its intention to support the proposal to amend GXs amended and restated certificate of incorporation to extend the date by which GX must complete its initial business combination from May 23, 2021 to July 31, 2021 (the "Extension" and such later date, the "Extended Date"). This proposal will be voted o...

Message : Required fields NEW YORK, May 10, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ: GXGX), a publicly-traded special purpose acquisition company, today reaffirmed its intention to support the proposal to amend GXs amended and restated certificate of incorporation to extend the date by which GX must complete its initial business combination from May 23, 2021 to July 31, 2021 (the "Extension" and such later date, the "Extended Date"). This proposal will be voted on by stockho...

Share this article Share this article NEW YORK, April 16, 2021 /PRNewswire/ -- On April 14, 2021, GX Acquisition Corp. ("GX") (NASDAQ: "GXGX"), provided information regarding a proposal to amend GXs amended and restated certificate of incorporation (the "Charter") to extend the date by which GX has to complete its initial business combination (the "Extension") from May 23, 2021 to July 31, 2021. The Charter currently provides that GX has 24 months from the closing of its initial public offering...

03.03.21 -- Biotech Founders Share Insights On FDA, CMC, And GMP     As you gear up for your first-in-human studies, your chemistry, manufacturing, and controls (CMC) and medical affairs leaders will come together to play principle — and interdependent — roles in the success of those initiatives. On a recent episode of the  Business of Biotech podcast, Dr. Perez, chief medical officer, and Dr. Ihle, VP of CMC and quality, at Bolt Biotherapeutics, Inc., s...

03.02.21 -- Biotech Founders Share Insights On FDA, CMC, And GMP     As you gear up for your first-in-human studies, your chemistry, manufacturing, and controls (CMC) and medical affairs leaders will come together to play principle — and interdependent — roles in the success of those initiatives. On a recent episode of the  Business of Biotech podcast, Dr. Perez, chief medical officer, and Dr. Ihle, VP of CMC and quality, at Bolt Biotherapeutics, Inc., s...

CBRE announced that Jeffrey Dunne, Jeremy Neuer, Steve Bardsley, David Gavin, Gene Pride, Travis Langer and Zach McHale of CBRE’s Institutional Properties group, in partnership with CBRE’s Tom Sullivan, represented an institutional seller in the $46.6 million sale of 170 Park Avenue in Florham Park, New Jersey. 170 Park is fully leased on a long-term basis to Celularity, Inc. and serves as their corporate headquarters, lab, and manufacturing facility. The CBRE team was also responsible fo...

/PRNewswire/ -- JLL Income Property Trust, an institutionally managed daily NAV REIT (NASDAQ: ZIPTAX; ZIPTMX; ZIPIAX; ZIPIMX) with more than $3.5 billion in...

Landcadia Holdings III, Inc. (NASDAQ: LCY) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Landcadia Holdings III, Inc. (NASDAQ: LCY) in connection with the companys proposed merger with HMAN Group Holdings Inc., the parent company of The Hillman Group, Inc. ("Hillman").  Under the terms of the merger agreement, LCY will acquire Hillman through a reverse merger that will result in Hillman becoming a public company tra...

Share this article Share this article ResearchAndMarkets.coms offering. Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into a variety of cell types, including but not limited to osteoblasts, chondrocytes, myocytes, and adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cell types f...